Skip to main content

MoneyWorks4Me

The sales is pegged at Rs. 130.83 millions for the September 2023 quarter. The mentioned figure indicates decline with the sales recorded at Rs. 185.47 millions during the year-ago period.A big loss of -81.83% reported for the quarter ended September 2023 to Rs. 1.93  millions from Rs. 10.62 millions.The Operating Profit of the company witnessed a decrease to 16.81 millions from 31.05 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202309 202209 % Var 202309 202209 % Var 202303 202203 % Var
Sales 130.83 185.47 -29.46 281.96 364.81 -22.71 661.71 694.30 -4.69
Other Income 1.71 0.95 80.00 1.99 1.11 79.28 5.11 5.92 -13.68
PBIDT 16.81 31.05 -45.86 41.62 59.77 -30.37 92.87 90.07 3.11
Interest 5.19 7.17 -27.62 11.28 12.91 -12.63 23.82 20.66 15.30
PBDT 11.62 23.88 -51.34 30.34 46.86 -35.25 69.05 69.41 -0.52
Depreciation 9.04 9.73 -7.09 17.84 19.36 -7.85 39.17 35.48 10.40
PBT 2.58 14.15 -81.77 12.50 27.50 -54.55 29.88 33.93 -11.94
TAX 0.65 3.53 -81.59 3.13 6.87 -54.44 7.47 7.50 -0.40
Deferred Tax 0.47 0.47 0.00 0.88 0.88 0.00 1.97 3.05 -35.41
PAT 1.93 10.62 -81.83 9.37 20.63 -54.58 22.41 26.43 -15.21
Equity 54.85 54.85 0.00 54.85 54.85 0.00 54.85 54.85 0.00
PBIDTM(%) 12.85 16.74 -23.25 14.76 16.38 -9.91 14.03 12.97 8.19
Peers
Company Name CMP
Sun Pharma. Inds. 1880.90
Dr. Reddys Labs. 1377.00
Cipla 1393.00
Lupin 1980.00
Zydus Lifesciences 1191.00
View more..